Ventriculoperitoneal shunt in patients with leptomeningeal metastasis
- PMID: 15883329
- DOI: 10.1212/01.WNL.0000160396.69050.DC
Ventriculoperitoneal shunt in patients with leptomeningeal metastasis
Abstract
The authors reviewed 37 patients with leptomeningeal metastasis (LM) who required a ventriculoperitoneal shunt (VP shunt) for management of intracranial hypertension. Improvement was seen in 27 (77%) patients; subdural hematoma developed in one and shunt malfunction in three. Median overall survival was 2 months (range 2 days to 3.6 years) after VP shunt placement, but there was no procedure-related mortality. The prognosis of LM remained poor, but VP shunt can be an effective palliative tool when required.
Comment in
-
Ventriculoperitoneal shunt in patients with leptomeningeal metastasis.Neurology. 2006 Mar 14;66(5):783; author reply 783. doi: 10.1212/01.wnl.0000205135.85388.01. Neurology. 2006. PMID: 16534138 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources